A federal judge handed down a decision this week in a lawsuit involving the 340B prescription drug discount program as hospitals, physicians, and drug manufacturers continue to battle over how the ...
Another front opens in the battle between hospitals and drugmakers over the 340B drug discount program Good afternoon, and thanks for checking in with the Health Brief newsletter. Please send any tips ...
The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more ...
The hospital lobby is asking federal officials to head off expanded data collection policies some drugmakers are implementing for providers participating in the 340B drug discount program.
AHA urges HHS to block Novo Nordisk's 340B data demand, citing legal and cost concerns for safety-net hospitals and covered entities.
A new Ohio bill won't expand the 340B program, but it will protect patients' ability to fill prescriptions at their pharmacy of choice.
The AHA March 3 urged the Health Resources and Services Administration to take immediate action to stop a new Novo Nordisk ...
AHA letter to the Health Resources and Services Administration about a new concerning development with the 340B Program.
The UPMC Center for High-Value Health Care recently received an award of $3.26 million from the Health Resources and Services Administration. This substantial funding will support projects focusing on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results